GE Medical Systems and Cytogen have teamed up to market a prostate molecular imaging system built on GE's new Infinia Hawkeye SPECT/CT system and Cytogen's ProstaScint radiolabeled monoclonal antibody. Waukesha, WI-based GE will provide installation and customer service activities, while Cytogen of Princeton, NJ, will handle technical support for ProstaScint fusion imaging. The firms also said they would work together to advance patient and physician awareness of fusion imaging.
By AuntMinnie.com staff writersJune 24, 2003
Related Reading
GE debuts Infinia Hawkeye, June 23, 2003
Cytogen to reacquire Quadramet rights, June 16, 2003
Cytogen, DraxImage terminate brachytherapy agreement, April 9, 2003
Cytogen 2002 loss grows despite revenue gains, February 26, 2003
Cytogen, Draxis dispute heats up, January 28, 2003
Copyright © 2003 AuntMinnie.com
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
